Atlas Trials

A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects

Clinical trial NCT03516331 · COMPLETED

Trial details

NCT number
NCT03516331
Sponsor
Flatley Discovery Lab LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2018-03-07
Primary completion
2018-08-22
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.